Onetime investors' pet stock Freshpet (NASDAQ: FRPT) wasn't such a good boy over the past few days. On the back of a recommendation downgrade from one analyst and price target cuts from two others, investors...
/Lululemon%20Athletica%20inc_%20storefront%20by-%20Robert%20Way%20via%20iStock.jpg)
Although Lululemon has trailed the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock.
/CNW/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $10.7 million or $1.04 basic earnings per share for the...
The S&P 500 (SNPINDEX: ^GSPC) advanced 23% last year as investors cheered economic resilience and potential productivity gains from artificial intelligence. Admittedly, the index faltered in December as...
C3.ai (NYSE: AI) stock is seeing sell-offs in Wednesday's trading. The software and consulting specialist's share price was down 4% as of 1:20 p.m. ET today. Meanwhile, the S&P 500 index had fallen 0.6%,...
Nvidia (NASDAQ: NVDA) stock may have soared by about 170% in 2024, but shares of the leading artificial intelligence (AI) semiconductor maker haven't done much in the most recent three months.
An analyst upgrade was the news pushing Fastly 's (NYSE: FSLY) stock more than 16% higher as the last trading month of the year kicked off on Monday. That made the content delivery network (CDN) specialist...
/Moody's%20Corp_%20phone%20with%20blue%20background-by%20IgorGolovniov%20via%20Shutterstock.jpg)
Moody's has surpassed the overall market performance this year, and Wall Street analysts hold a cautiously positive view on the stock’s future outlook.
Sales growth is tapering off for this provider of delivery services for transplant organs.